Conversely, low and high levels of NOXA, which binds MCL1 to reduce its anti-apoptotic buffering potential, was associated with venetoclax resistance and sensitivity, respectively, in acute myeloid leukemia [8]. Here, MCL1 is linked to acute myeloid leukemia.